本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tempest Therapeutics Inc.

0.7601
-0.0099-1.29%
盘后:0.7500-0.0101-1.33%19:54 EDT
成交量:18.27万
成交额:13.97万
市值:1,283.79万
市盈率:-0.17
高:0.8100
开:0.7764
低:0.7600
收:0.7700
52周最高:12.23
52周最低:0.7432
股本:1,688.98万
流通股本:959.84万
量比:0.29
换手率:1.90%
股息:- -
股息率:- -
每股收益(TTM):-4.5617
每股收益(LYR):-19.4955
净资产收益率:-931.14%
总资产收益率:-79.37%
市净率:-11.78
市盈率(LYR):-0.04

数据加载中...

2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/10

重要事件披露

Form 8-K - Current report
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/18

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments